Numinus Wellness Stock (OTC:NUMIF), Trade Ideas

Numinus Wellness Inc develops proprietary, psychedelic-centered, therapeutic products and services through its laboratory and research & development processes. The company's clinic network consists of Numinus Health, Mindspace Services, and the Neurology Center of Toronto. Its services include Ketamine-assisted psychotherapy for depression, neurological care, psychotherapy, and counseling by registered psychologists among others. The company's operating segments are; Clinical research operations, Canadian clinic network, US clinic network and Corporate. The majority of the revenue for the company is generated from US clinic network segment. Geographically, the company has its presence in United States and Canada.

financial psychedelics (Zita and canadastock on Shutterstock)

Biotech

Cannabis

Earnings

News

Psychedelics

NUMIF

Numinus Wellness Q2 2024 Revenue Declines Amid Clinic Reshuffling And Expected Industry Trends

psychedelic chemistry Olia Danilevich by Pexels - Copy

Contracts

Management

Global

MDXXF

OPTHF

Two Top Biotechs Forge MDMA Supply Deals For An Expanding Research Field

joshua-sukoff-1NnW4hAwOuQ-unsplash

Legal

Utah Hospitals Will Soon Provide Psilocybin And MDMA Therapy For Mental Health Conditions

NUMINUS WELLNESS INC by Numinus Wellness Inc.

Numinus Wellness Inc

Ripple Labs is pushing back against the hefty fine proposed by the U.S. Securities and Exchange Commission (SEC) in their <a href="https://www.benzinga.com/markets/cryptocurrency/24/03/37925205/ripple-faces-2b-sec-fine-crypto-company-vows-to-fight-misleading-charges">ongoing legal battle over XRP</a>.
What Happened: In a filing submitted on Monday, Ripple (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>) argues against the SEC&#8217;s request for a nearly $2 billion penalty, instead proposing a civil penalty of just $10 million, Coindesk <a href="https://www.coindesk.com/policy/2024/04/23/ripple-says-10m-penalty-enough-rejects-secs-ask-of-195b-fine-in-final-judgment/?utm_medium=social&amp;utm_content=editorial&amp;utm_term=organic&amp;utm_source=twitter&amp;utm_campaign=coindesk_main">reported</a>.
The SEC had previously urged the court to order Ripple to pay almost $2 billion, comprised of disgorgement, prejudgment interest and a civil penalty. 
While the court did find Ripple violated securities laws through some XRP sales, it dismissed the SEC&#8217;s broader claims regarding XRP sales on exchanges and through algorithms.
Ripple&#8217;s lawyers strongly criticized the SEC&#8217;s proposed fine, calling it &#8220;administrative overreach.&#8221; 
They argue the SEC is acting as if they had won the entire case and proven &#8220;reckless conduct&#8221; by Ripple, which they say is not the reality. 
Additionally, Ripple contends the SEC is seeking disgorgement that is not legally permissible and a civil penalty far exceeding anything the SEC has obtained in a similar digital asset case.
The filing also included a redacted section detailing Ripple&#8217;s financial situation, arguing that with no net gains from the disputed XRP sales, there&#8217;s nothing to disgorge.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/events/digital-assets/"><img loading="lazy" decoding="async" width="300" height="250" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/03/27091545/Benzinga-conference.gif" alt="Benzinga future of digital assets conference" class="wp-image-267246" /></a></figure>
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/04/38361361/bitcoin-fomo-to-push-prices-to-a-different-level-mark-yusko">Bitcoin &#8216;FOMO&#8217; To Push Prices To A &#8216;Different Level&#8217;: Mark Yusko</a>
This latest development adds another layer of complexity to the ongoing lawsuit between Ripple and the SEC. 
The vast difference between the proposed fines highlights the significant disagreement between both parties.
The regulatory landscape surrounding cryptocurrencies remains unsettled, with cases like the SEC vs. Ripple raising crucial questions about the classification and sale of digital assets. 
What&#8217;s Next: If you&#8217;re interested in staying informed about the future of digital assets and the evolving regulatory environment, consider attending the Benzinga <a href="https://www.benzinga.com/events/digital-assets/agenda/">Future of Digital Assets</a> event on Nov. 19. 
This industry gathering will feature leading experts discussing <a href="https://www.benzinga.com/markets/cryptocurrency/24/04/38361443/macro-guru-raoul-pal-sees-perfect-chart-for-4b-people-to-adopt-crypto-by-2030">regulations, investment strategies</a>, and the latest innovations shaping the world of cryptocurrencies.
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$XRP

Ripple Vs. SEC Heats Up: Company Refuses $2B Fine, Proposes $10M

WIIM

XP shares are trading lower after Morgan Stanley downgraded the stock from Overweight to Equal-Weight and lowered its price target from $31 to $24.

Tech billionaire Elon Musk's social media platform X, formerly Twitter, is currently down. The homepage shows a "Welcome to X!" message while posts either don't load or show media and replies.
What Happened: Musk's social media platform X is facing a downtime with many users expressing grief on rival platforms including Jack Dorsey-Backed Bluesky and Mark Zuckerberg&#8216;s Threads
<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="673" height="600" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/23100518/Twitter-down-screenshot.jpg" alt="" class="wp-image-304533" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/23100518/Twitter-down-screenshot.jpg 673w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/23100518/Twitter-down-screenshot-300x267.jpg 300w" sizes="(max-width: 673px) 100vw, 673px" /><figcaption class="wp-element-caption">Screenshot of X</figcaption></figure>
According to the downtime detection <a href="https://downforeveryoneorjustme.com/twitter">service</a>, Downforeveryoneorjustme, issues with X began a little over 20 minutes ago. There is currently a massive spike in error reports, according to the service.
See Also: <a href="https://www.benzinga.com/news/24/04/38375786/elon-musk-hates-annoying-instagram-logo-that-pops-up-in-reels-posted-on-x-makes-things-worse">Elon Musk Hates &#8216;Annoying&#8217; Instagram Logo That Pops Up In Reels Posted On X: &#8216;Makes Things Worse&#8217;</a>
<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="707" height="449" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/23100443/Twitter-errors-down.jpg" alt="" class="wp-image-304528" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/23100443/Twitter-errors-down.jpg 707w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/23100443/Twitter-errors-down-300x191.jpg 300w" sizes="(max-width: 707px) 100vw, 707px" /><figcaption class="wp-element-caption">X downtime error reports</figcaption></figure>
This is the second major outage at X detected this month – the last outage was on April 11, and it lasted for an hour.
<figure class="wp-block-image size-large"><img decoding="async" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/23101158/Screenshot-2024-04-23-at-7.41.41%E2%80%AFPM-1024x751.png" alt="" class="wp-image-304569" /></figure>
<figure class="wp-block-image size-large"><img decoding="async" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/23101133/Screenshot-2024-04-23-at-7.41.20%E2%80%AFPM-1024x524.png" alt="" class="wp-image-304565" /></figure>
Subscribe to the <a href="https://bztechtrends.beehiiv.com/subscribe" target="_blank" rel="noreferrer noopener">Benzinga Tech Trends newsletter</a> to get all the latest tech developments delivered to your inbox.
<a href="https://pro.benzinga.com/dashboard">Benzinga</a> has reached out to X for a statement, we will update the story as soon as we get a response.
Check out more of Benzinga's Consumer Tech coverage by&nbsp;<a href="https://www.benzinga.com/topic/consumer-tech" target="_blank" rel="noreferrer noopener">following this link</a>.
Read Next:&nbsp;<a href="https://www.benzinga.com/general/entertainment/24/04/38345794/mark-zuckerberg-spills-the-beans-on-his-bromance-with-nvidias-jensen-huang-hell-yeah-lets-m" target="_blank" rel="noreferrer noopener">Mark Zuckerberg Spills The Beans On His Bromance With Nvidia's Jensen Huang: ‘Hell Yeah, Let's Make Cheesesteaks'</a>
Image via Shutterstock

Social Media

Tech

BREAKING: Elon Musk's X Is Down, It's Not Just You

Uranium prices have more support now than they did when the nuclear fuel hit its all-time high in 2007, according to the chief executive <a href="https://www.benzinga.com/topic/uranium">of uranium explorer</a> Madison Metals Inc. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MMTLF#OTC">MMTLF</a>).
Back then, when uranium reached a record high above $130 per pound, physical supply was tight because of flooding at two major mines, falling recoveries from old nuclear warheads, expectations of a nuclear renaissance and the launch of uranium futures in New York.
But the high price proved to be a bubble, quickly falling as end users stopped buying and financial services companies sold the metal. Later, in 2011, a disaster at a Japanese nuclear reactor sent the uranium market into a deep slump for years as nations shut down nuclear reactors.
The underlying fundamentals are "dramatically different" now, CEO Duane Parnham told Benzinga.
Also Read: <a href="https://www.benzinga.com/markets/commodities/24/04/38187293/uranium-execs-talk-high-prices-tout-projects-as-long-downturn-comes-to-an-end-the-us-governme">Uranium Execs Talk High Prices, Tout Projects As Long Downturn Comes To An End: &#8216;The US Government Will Be Buying&#8217;</a>
The tables have indeed turned. Around 60 reactors are under construction around the world, and an additional 110 are planned, according to the World Nuclear Association. That's in sharp contrast to the 65 reactors that, according to the International Atomic Energy Agency, were shut down or didn't have their life spans extended between 2011 and 2020.
The threat of climate change has helped temper opposition from environmentalists concerned about safety and waste. At the United Nations climate conference last year, 22 nations pledged to triple nuclear generation by 2050 from a 2020 baseline.
The energy transition away from fossil fuels toward net zero emissions though electrification means there will be a much greater need for carbon-free power generation, and wind and solar currently aren't able to meet base load power generation requirements.
"Nuclear really became the solution to that," Parnham said. "It's becoming more accepted."
According to a base case scenario from the World Nuclear Association, global demand from reactors could hit almost 130,000 metric tons by 2040, up substantially from the estimated demand of about 65,650 metric tons this year. But by 2040 supply from existing, prospective or planned mines or those now under development may total less than 80,000 metric tons, the group said.
"We've really got to start developing mines now," Parnham said.
Mine development and exploration has been underfunded because of the longtime slump in uranium prices, which dipped below $20 a pound in 2016.&nbsp;
Meanwhile, uranium purchases from investors and trading firms have become "significant," Parnham said.&nbsp;
On top of utilities buying uranium for reactors and governments making purchases for strategic stockpiles, demand from financial services companies "dries up what little supply is out there," he said.
One of the most prominent examples is the Sprott Physical Uranium Trust (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SRUUF#OTC">SRUUF</a>), which is an exchange traded fund that sells shares backed by physical uranium held in storage. Since its inception in 2021, the fund has amassed nearly 64 million pounds of uranium.
The buying from the financial market creates price volatility because the financial players will "flood the market" when prices start to come down, he said.&nbsp;
There may come a time when so much financial services money is entering the uranium market that governments will have to step in with regulation, but "we're a ways away from that," he said.
In the meantime, the higher uranium price is spurring merger and acquisition activity among uranium miners, as acquisitions offer the quickest way to grow, he said.&nbsp;
Indeed, recent merger and acquisition activity in the uranium space has included Premier American Uranium Inc.&nbsp;(OCT: PAUIF) and American Future Fuel Corp. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/AFFCF#OTC">AFFCF</a>); Boss Energy Ltd. (BQSSF) and enCore Energy Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EU#NASDAQ">EU</a>); ATHA Energy Corp. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SASKF#OTC">SASKF</a>) and Latitude Uranium Inc. and 92 Energy; and IsoEnergy Ltd. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ISENF#OTC">ISENF</a>) and Consolidated Uranium Inc.
"Pricing does motivate M and A," Parnham said.
Now Read: <a href="https://www.benzinga.com/government/24/03/37680603/ur-energy-to-develop-wyoming-uranium-mine-as-prices-soar-sales-contracts-grow">Ur-Energy To Develop Wyoming Uranium Mine As Prices Soar, Sales Contracts Grow</a>
Photo: Shutterstock

Specialty ETFs

Commodities

Exclusives

Markets

ETFs

AFFCF

ISENF

MMTLF

PAUIF

SASKF

SRUUF

EXCLUSIVE: Why This Uranium Bull Market Is Different — 'We've Really Got To Start Developing Mines,' Says Madison Metals CEO

JMP Securities analyst Patrick Walravens reiterates ServiceNow (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOW#NYSE">NOW</a>) with a Market Outperform and maintains $825 price target.

Price Target

Reiteration

Analyst Ratings

JMP Securities Reiterates Market Outperform on ServiceNow, Maintains $825 Price Target

New York Prosecutors Ask Judge To Fine Trump $10,000 For Violating Gag Order In Hush Money Criminal Trial

UBS analyst Erika Najarian maintains Zions Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZION#NASDAQ">ZION</a>) with a Neutral and lowers the price target from $47 to $45.

ZION

UBS Maintains Neutral on Zions Bancorp, Lowers Price Target to $45

Former President Donald Trump is reportedly using his ongoing trial as a platform to portray himself as a superhero fighting against the system.
What Happened: Sidney Blumenthal, a former senior adviser to President Bill Clinton, recently <a href="https://www.theguardian.com/commentisfree/2024/apr/23/trump-trial-superhero-shadow">wrote </a>in The Guardian about Trump&#8217;s strategy for his current trial. The ex-president is said to be attempting to flip the script, presenting the prosecution as persecution and using the trial as a campaign trail.
&#8220;Trump has strategized that he could use the trial as his platform to depict himself as the superhero against the system,&#8221; Blumenthal wrote.
Trump&#8217;s approach, as described by Blumenthal, is to position himself as a victim of the &#8220;forces of evil elites&#8221; and inflate his image into a larger-than-life fighter for his followers. He reportedly declared, "I am your retribution!"
However, despite his efforts to control the narrative, Trump&#8217;s actions within the courtroom are restricted. The judge ordered him to sit down when he attempted to leave before adjournment, highlighting the limitations on his &#8220;superhero&#8221; persona.
See Also: <a href="https://www.benzinga.com/news/24/04/38348277/trump-vs-biden-nationwide-poll-shows-key-issue-decidedly-tilts-equation-in-favor-of-one-candidate?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Trump vs. Biden: Nationwide Poll Shows Key Issue Decidedly Tilts Equation In Favor Of One Candidate</a>
The trial, according to Blumenthal, is more than a legal proceeding for Trump; it is a spectacle that raises the central issue at stake in his cult of personality. Trump&#8217;s promise to testify reveals his understanding of the trial as a public spectacle, despite the potential legal risks.
Trump&#8217;s trial strategy appears to be aimed at maintaining his image as a strongman for his followers. However, the reality of the courtroom and the legal process may prove to be a significant challenge to this narrative.
Why It Matters: Trump&#8217;s potential decision to <a href="https://www.benzinga.com/news/24/04/38369620/trump-taking-the-stand-in-ny-hush-money-trial-would-really-be-a-death-knell-says-ex-doj-attorney-not">testify could be detrimental to his case</a>. Andrew Weissmann, a former Assistant U.S. Attorney and law professor, warned that testifying could pose significant risks for the former president.
Moreover, Trump has been accused of violating a gag order multiple times by Manhattan prosecutors. If found <a href="https://www.benzinga.com/news/24/04/38368871/trump-allegedly-violated-gag-order-10-times-will-hush-money-judge-show-leniency-on-contempt-charges">guilty of breaching the gag order,</a> Trump could face penalties ranging from a warning to a short jail term.
Read Next: <a href="https://www.benzinga.com/general/politics/24/04/38362005/donald-trump-may-soon-receive-36-million-more-djt-shares-key-milestone-ahead?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Donald Trump May Soon Receive 36 Million More DJT Shares: Key Milestone Ahead</a>
Image via Shutterstock
<div style="font-family: 'Lato', sans-serif">
<div>
<hr style="border: 0;height: 5px;background: #225aa9" />
<div style="background-color: #f5f5f5;background-position: center;background-size: cover;justify-content: center"></div>

 Engineered by Benzinga Neuro, Edited by 
 <a href="https://www.benzinga.com/topic/Pooja-Rajkumari" target="_blank" rel="noopener" style="color: #225aa9;text-decoration: none">Pooja Rajkumari</a> 
 
 
<hr style="border: 0;height: 1px;background: #225aa9" />

 The GPT-4-based Benzinga Neuro content generation system exploits the extensive Benzinga Ecosystem, including native data, APIs, and more to create comprehensive and timely stories for you. 
 <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noopener" style="color: #225aa9;text-decoration: none">Learn more.</a>
 
<hr style="border: 0;height: 5px;background: #225aa9" />
 </div>
</div>

Politics

General

Hush Money Trial Or A 'Superhero' Story? Former Presidential Adviser Reveals Trump's 'Retribution' Plans

<a href="https://www.macrumors.com/2024/04/23/apple-developing-its-own-ai-server-processor/" title="https://www.macrumors.com/2024/04/23/apple-developing-its-own-ai-server-processor/">https://www.macrumors.com/2024/04/23/apple-developing-its-own-ai-server-processor/</a>

AAPL

'Apple Reportedly Developing Its Own Custom Silicon for AI Servers' -Mac Rumors Report

Ford Motor Co&#8216;s F-150 Lightning EV pickup truck seemingly saved a day for children earlier this year. 
What Happened: EV enthusiast Justin Horn in January shared a short video of an F-150 Lightning powering a bounce house after the generator turned off unexpectedly with kids inside. 
The Lightning owner rushed and got it plugged into the pump real quick, Horn wrote in his post. 
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Told my buddy to switch the bounce house over to his <a href="https://twitter.com/Ford?ref_src=twsrc%5Etfw">@Ford</a> Lighting, he was planning to do it anyway &amp; I was going to take a funny "staged" video… but then the generator turned off unexpectedly with kids inside. He rushed over and got it plugged really quick. <a href="https://twitter.com/jimfarley98?ref_src=twsrc%5Etfw">@jimfarley98</a> <a href="https://t.co/VssoULsACg">pic.twitter.com/VssoULsACg</a>
&mdash; Justin Horn (@justin_horn) <a href="https://twitter.com/justin_horn/status/1749146318591725686?ref_src=twsrc%5Etfw">January 21, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
The Lightning has power outlets in the cab, bed, and frunk of the vehicle. In the video, the house is seemingly connected to the power outlet in the truck bed. 
The video was shared by Ford CEO Jim Farley on Monday.
Why It Matters: The Lightning can even power homes in case of a power outage if the home is properly equipped. It&nbsp;<a href="https://www.benzinga.com/news/22/03/26095811/ford-ties-up-with-pg-e-to-pilot-bidirectional-ev-charging-as-power-source-for-homes" target="_blank" rel="noreferrer noopener">can power homes</a> for up to three days or even 10 if usage is properly rationed, according to the automaker.
Lightning&#8217;s key rival Cybertruck can also power tools. The Cybertruck is the<a href="https://www.benzinga.com/news/24/03/37814648/own-a-cybertruck-it-can-soon-power-your-home-says-tesla-exec"> only Tesla equipped with powershare</a> to charge homes or other EVs. 
Check out more of Benzinga's Future Of Mobility coverage by&nbsp;<a href="http://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link</a>.
Read More:&nbsp;<a href="https://www.benzinga.com/news/24/04/38373389/tesla-ceo-elon-musk-takes-swipe-at-waymo-says-cybertruck-might-be-needed-for-robotaxis-in-san-franci">Tesla CEO Elon Musk Takes Swipe At Waymo, Says Cybertruck Might Be Needed For Robotaxis In San Francisco Amid Vandalism Frenzy</a>
Photo via Shutterstock

Ford CEO Jim Farley Reposts Video Of F-150 Lightning Powering A Bounce House After Generator Failed

BMO Capital analyst John McNulty maintains PPG Indus (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PPG#NYSE">PPG</a>) with a Outperform and lowers the price target from $168 to $165.

BMO Capital Maintains Outperform on PPG Indus, Lowers Price Target to $165

BMO Capital analyst Jeremy Mccrea maintains PrairieSky Royalty (TSX:<a class="ticker" href="https://www.benzinga.com/stock/PSK#TSX">PSK</a>) with a Outperform and raises the price target from C$30 to C$33.

TSX:PSK

BMO Capital Maintains Outperform on PrairieSky Royalty, Raises Price Target to C$33

LKQ shares are trading lower after the company reported a Q1 earnings miss and cut its FY24 outlook.

JMP Securities analyst Joe Goodwin reiterates Model N (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MODN#NYSE">MODN</a>) with a Market Perform.

MODN

JMP Securities Reiterates Market Perform on Model N

Riot Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIOT#NASDAQ">RIOT</a>) has outperformed the market over the past 5 years by 6.52% on an annualized basis producing an average annual return of 17.86%. Currently, Riot Platforms has a market capitalization of $2.99 billion. 
Buying $100 In RIOT: If an investor had bought $100 of RIOT stock 5 years ago, it would be worth $225.23 today based on a price of $11.78 for RIOT at the time of writing.
<h3>Riot Platforms's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1713880851_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

RIOT

$100 Invested In Riot Platforms 5 Years Ago Would Be Worth This Much Today

Meta Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) has outperformed the market over the past 10 years by 13.43% on an annualized basis producing an average annual return of 23.78%. Currently, Meta Platforms has a market capitalization of $1.24 trillion. 
Buying $100 In META: If an investor had bought $100 of META stock 10 years ago, it would be worth $874.40 today based on a price of $490.68 for META at the time of writing.
<h3>Meta Platforms's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1713880846_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much You Would Have Made Owning Meta Platforms Stock In The Last 10 Years

Macro Economic Events

Econ #s

Economics

USA New Home Sales (MoM) For March 8.8% Vs -5.1% Prior

In the preceding three months, 4 analysts have released ratings for Addus HomeCare (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADUS#NASDAQ">ADUS</a>), presenting a wide array of perspectives from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $97.75, a high estimate of $118.00, and a low estimate of $83.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 17.16%. 
<img src="https://www.benzinga.com/files/images/story/2024/1713880831_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
The standing of Addus HomeCare among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Andrew Mok</td>
<td>Barclays</td>
<td>Announces</td>
<td>Underweight</td>
<td>$83.00</td>
<td>-</td>
</tr>
<tr>
<td>Michael Wiederhorn</td>
<td>Oppenheimer</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$118.00</td>
<td>$118.00</td>
</tr>
<tr>
<td>Andrew Mok</td>
<td>Barclays</td>
<td>Announces</td>
<td>Equal-Weight</td>
<td>$88.00</td>
<td>-</td>
</tr>
<tr>
<td>Ben Hendrix</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$102.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Addus HomeCare. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Addus HomeCare compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for Addus HomeCare's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Addus HomeCare's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/ADUS/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Addus HomeCare analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>Get to Know Addus HomeCare Better</h2>
Addus HomeCare Corp is engaged in the provision of in-home personal care services. It operates through the segments such as Personal care segment, which is a key revenue driver, provides non-medical assistance with activities of daily living, primarily to persons who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. The Hospice segment provides physical, emotional and spiritual care for people who are terminally ill and their families. Its Home health segment provides services that are primarily medical in nature to those individuals who may require assistance during an illness or after surgery.
<h3>Addus HomeCare: Financial Performance Dissected</h3>
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
Revenue Growth: Addus HomeCare displayed positive results in 3 months. As of 31 December, 2023, the company achieved a solid revenue growth rate of approximately 11.86%. This indicates a notable increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Health Care sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 7.08%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Addus HomeCare's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 2.81% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Addus HomeCare's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 1.9%, the company showcases efficient use of assets and strong financial health.
Debt Management: Addus HomeCare's debt-to-equity ratio is below the industry average. With a ratio of 0.25, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>The Basics of Analyst Ratings</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ADUS

Cracking The Code: Understanding Analyst Reviews For Addus HomeCare

Eastern Bankshares's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EBC#NYSE">EBC</a>) short percent of float has risen 3.75% since its last report. The company recently reported that it has 4.84 million shares sold short, which is 2.77% of all regular shares that are available for trading. Based on its trading volume, it would take traders 6.16 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Eastern Bankshares Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1713880829_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Eastern Bankshares has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Eastern Bankshares's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Eastern Bankshares's peer group average for short interest as a percentage of float is 5.13%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

How Is The Market Feeling About Eastern Bankshares?

Hamilton Lane's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HLNE#NYSE">HLNE</a>) short percent of float has fallen 11.83% since its last report. The company recently reported that it has 876 thousand shares sold short, which is 2.31% of all regular shares that are available for trading. Based on its trading volume, it would take traders 4.21 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Hamilton Lane Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1713880823_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Hamilton Lane has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Hamilton Lane's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Hamilton Lane's peer group average for short interest as a percentage of float is 2.71%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

HLNE

Looking Into Hamilton Lane's Recent Short Interest

Numinus Wellness reports Q1 results

Psychedelic stocks gain after FDA priority review for MDMA therapy

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
A positive news update for Mind Medicine (NASDAQ:<a href="https://investorplace.com/stock-quotes/mnmd-stock-quote/">MNMD</a>) is elevating the entire psychedelic treatment sector today. Specifically, the U.S. Food and Drug Administration (FDA) has just granted midomafetamine capsules (MDMA) a <a href="https://seekingalpha.com/news/4065641-psychedelic-stocks-gain-fda-priority-review-mdma-therapy">priority review</a>.



If this results in regulatory approval, MindMedicine&rsquo;s product could make history as the country&rsquo;s &ldquo;first psychedelic-assisted therapy.&rdquo; While the review is not scheduled until Aug. 11, 2023, MNMD stock is rising on the news today alongside many other companies in the space. Indeed, any type of regulatory success could grant a new legitimacy to the entire sector, thereby minting a new class of winning stocks. 



<h2>What&rsquo;s Happening With MNMD Stock?</h2>



News of the FDA priority review has made a good week even better for MindMedicine. As of this writing, MNMD stock is up more than 8% for the day, with gains of 22% for the past five days. Despite some volatility late in January 2024, shares seem to have recovered well and are making up lost ground. If this growth continues, MNMD stock won&rsquo;t trade at penny stock levels much longer. 



Of course, it&rsquo;s important to note that the company that actually submitted the drug application behind today&rsquo;s momentum isn&rsquo;t MindMedicine. Instead, it&rsquo;s a biotech firm called Lykos Therapeutics, which seeks to use MDMA for treating post-traumatic stress disorder (PTSD) &ldquo;in combination with other psychological interventions.&rdquo; 



Lykos isn&rsquo;t publicly traded, but many of its biotech peers are performing well in the market today. For example, micro-cap penny stock Numinus Wellness (OTCMKTS:<a href="https://investorplace.com/stock-quotes/numif-stock-quote/">NUMIF</a>) stock is up 4% while Compass Pathways (NASDAQ:<a href="https://investorplace.com/stock-quotes/cmps-stock-quote/">CMPS</a>) is outpacing even MNMD with gains of over 9% (although that growth is also partly due to Bank of New York Mellon (NYSE:<a href="https://investorplace.com/stock-quotes/bk-stock-quote/">BK</a>) <a href="https://www.marketbeat.com/instant-alerts/nasdaq-cmps-sec-filing-2024-02-12/">purchasing a large stake</a> in the company).



<h2>The Next Steps</h2>



As InvestorPlace contributor Alex Sirois notes, psychedelic stocks were <a href="https://investorplace.com/2023/06/the-3-best-psychedelic-stocks-to-buy-now/">&ldquo;taboo until recently.&rdquo;</a> Now, the new focus on MDMA <a href="https://www.nytimes.com/2023/09/14/health/mdma-ptsd-psychedelics.html">as a means of therapy</a> has helped these equities gain legitimacy in the biotech space. If a company like Lykos gains regulatory approval, it may be exactly what the sector needs to move upward. 



With the review still months away, names like MNMD stock will likely dip again in the near future. However, as August draws closer, they could rise again on momentum. If the FDA gives Lykos&rsquo; treatment a thumbs up, it will send the entire sector surging.



On Penny Stocks and Low-Volume Stocks:&#8239;With only the rarest exceptions,&nbsp;InvestorPlace&nbsp;does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;InvestorPlace.com&rsquo;s&nbsp;writers disclose this fact and warn readers of the risks.&nbsp;



Read More:&#8239;<a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/">Penny Stocks &mdash;&nbsp;How to Profit Without Getting Scammed</a>



On the date of publication, Samuel O&rsquo;Brient&nbsp;did not hold (either directly or indirectly) any positions in the securities mentioned in this article.&nbsp;The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<div>Samuel O&rsquo;Brient is a Reporter for InvestorPlace, where his work focuses primarily on financial markets, global economic trends, and public policy. O&rsquo;Brient writes a weekly column on recent political news that investors should be following.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/02/why-is-mindmed-mnmd-stock-up-8-today/">Why Is MindMed (MNMD) Stock Up 8% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is MindMed (MNMD) Stock Up 8% Today?

Oregon House passes bill to end hard drug decriminalization

Mind Medicine sends psychedelic stocks higher after FDA status for LSD formulation

PharmAla Biotech signs sale agreement with Numinus Wellness

Numinus Wellness Q2 Earnings Preview

Notable earnings after Monday's close

Numinus Wellness reports Q2 results

Numinus Wellness Inc. (NUMIF) Q2 2024 Earnings Call Transcript

ACRHF

ATAI

ATNF

CMND

CMPS

CRLBF

CURLF

CYBN

DRUG

ENVB

GHRS

GTBIF

IMBBY

JAPAY

MARK

MITK

MMNFF

MNMD

MYCOF

RVVTF

SEEL

SPRC

VUZI

Small Cap

Press Releases

Numinus Wellness Submits Clinical Trial Application

Financing

PharmAla Biotech Signs Sale Agreement with Numinus

Numinus to Host Q2 Fiscal 2024 Results Conference Call on April 15, 2024

Numinus Wellness Inc. Announces Second Quarter Fiscal 2024 Results

Numinus Wellness Provides Corporate Update

Cedar Clinical Research selected as clinical research site for Cybin's Phase 3 Study of CYB003

CSE:MDMA

TSX:NUMI

Numinus Wellness